No significant difference in dementia risk was observed between SGLT2 inhibitors versus GLP1 receptor agonists
Based on class data from authorised GLP-1 RA SmPCs, prescribers should consider therapeutic drug monitoring or clinical assessment when initiating retatrutide in patients taking medicines such as: Digoxin used for heart failure and atrial fibrillation
In line with our short-term metabolic analyses, previous studies in New Zealand obese and diet-induced obese male mice suggested that GLP1/E acts primarily at central levels to reverse metabolic alterations by decreasing food intake and body weight, while the potential beneficial effects on pancreatic beta-cells were possibly secondary and indirectly-mediated 33,48
Nature Medicine, 2024 Jan5;30(1):168176
they are nourishing and address skin concerns effectively
Finally, in other European markets where obesity drugs are marketed (Denmark, Norway, Spain, and Italy), reimbursement by the public insurance system is not provided